Literature DB >> 6490109

Partial C4 deficiency in subacute sclerosing panencephalitis.

C Rittner, E M Meier, B Stradmann, C M Giles, R Köchling, E Mollenhauer, H W Kreth.   

Abstract

In an immunogenetic study, 23 subacute sclerosing panencephalitis (SSPE) patients and their families were studied for the HLA region markers HLA-A, B, C, DR, BF, C2, C4A, C4B, GLO I, and PGM3. In addition, C3, C4, and factor B serum levels were determined. A highly significant association of C4A QO with SSPE was found. Furthermore, two rare haplotypes, C4A QOB QO, two C4ACh+ allotypes, and four Ch partial inhibitors were detected, which possibly impair the function of the C4 molecules. HLA-DR5 was increased. In addition, a number of rare HLA-A, C, B, DR haplotypes were observed. It is postulated that rare C4 molecular deficiency might be a predisposing factor in the pathogenesis of SSPE.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6490109     DOI: 10.1007/bf00345615

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  19 in total

1.  Neutralization of sensitized virus by the fourth component of complement.

Authors:  C A Daniels; T Borsos; H J Rapp; R Snyderman; A L Notkins
Journal:  Science       Date:  1969-08-01       Impact factor: 47.728

2.  Genetics of human C4 polymorphism: detection and segregation of rare and duplicated haplotypes.

Authors:  C Rittner; C M Giles; M H Roos; P Démant; E Mollenhauer
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

3.  The C4 system: quantitative studies of different genotypes.

Authors:  B Olaisen; P Teisberg; R Jonassen
Journal:  Immunobiology       Date:  1980       Impact factor: 3.144

4.  Letter: HL-A W29 and subacute sclerosing panencephalitis.

Authors:  J E Kurent; J L Sever; P I Terasaki
Journal:  Lancet       Date:  1975-04-19       Impact factor: 79.321

5.  Scleroderma: possible significance of silent alleles at the C4B locus.

Authors:  E Mollenhauer; R Schmidt; M Heinrichs; C Rittner
Journal:  Arthritis Rheum       Date:  1984-06

6.  Human C4 polymorphism: pedigree analysis of qualitative, quantitative, and functional parameters as a basis for phenotype interpretations.

Authors:  G Mauff; K Bender; C M Giles; S Goldmann; W Opferkuch; B Wachauf
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

7.  The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.

Authors:  D E Isenman; J R Young
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

8.  Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus.

Authors:  C G Jackson; H D Ochs; R J Wedgwood
Journal:  N Engl J Med       Date:  1979-05-17       Impact factor: 91.245

9.  A molecular basis for the two locus model of human complement component C4.

Authors:  M H Roos; E Mollenhauer; P Démant; C Rittner
Journal:  Nature       Date:  1982-08-26       Impact factor: 49.962

10.  Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.

Authors:  A H Fielder; M J Walport; J R Batchelor; R I Rynes; C M Black; I A Dodi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05
View more
  13 in total

Review 1.  The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system.

Authors:  M Hessing
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

2.  Allelic associations of multiple RFLPs of the gene encoding complement protein C2.

Authors:  Z B Zhu; J E Volanakis
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

3.  Immunoglobulins and complement factor C4 in adult rhinosinusitis.

Authors:  M Seppänen; J Suvilehto; M-L Lokki; I-L Notkola; A Järvinen; H Jarva; I Seppälä; O Tahkokallio; H Malmberg; S Meri; V Valtonen
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 4.  Complement activation and complement receptors in systemic lupus erythematosus.

Authors:  J P Atkinson
Journal:  Springer Semin Immunopathol       Date:  1986

5.  Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A.

Authors:  M C Carroll; D M Fathallah; L Bergamaschini; E M Alicot; D E Isenman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Possible association of sudden infant death with partial complement C4 deficiency revealed by post-mortem DNA typing of HLA class II and III genes.

Authors:  P M Schneider; C Wendler; T Riepert; L Braun; U Schacker; M Horn; H Althoff; R Mattern; C Rittner
Journal:  Eur J Pediatr       Date:  1989-12       Impact factor: 3.183

7.  Chromosomal aberrations in patients with primary biliary cirrhosis.

Authors:  A Notghi; U Nestle; G Rittner; P Brissot; H Jouanolle; M Manns; E Schleiermacher; C Rittner
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

8.  C4 uremic variant: an acquired C4 allotype.

Authors:  T R Welch; L Beischel
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

9.  Genetic basis of human complement C4A deficiency. Detection of a point mutation leading to nonexpression.

Authors:  G Barba; C Rittner; P M Schneider
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  C4 isotype deficiency in IgA nephropathy.

Authors:  T R Welch; A Berry; L S Beischel
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.